Gentamicin and tobramycin binding to human serum in vitro

Area of Science:

• Pharmacology
• Biochemistry
• Clinical Chemistry

Background:

• Gentamicin and tobramycin are critical aminoglycoside antibiotics used to treat severe bacterial infections.
• Understanding their interaction with human serum is essential for optimizing therapeutic efficacy and minimizing toxicity.
• Previous studies have suggested potential protein binding, but comprehensive analysis is lacking.

Purpose of the Study:

• To investigate the in vitro binding characteristics of gentamicin and tobramycin to human serum.
• To determine the extent of specific and non-specific binding of these drugs to serum components.
• To identify potential specific binding proteins in human serum for gentamicin and tobramycin.

Main Methods:

• In vitro equilibrium dialysis was employed using pooled human serum.
• Serum was supplemented with varying concentrations of either gentamicin or tobramycin.
• Scatchard analysis was performed across a range of drug concentrations to assess binding kinetics.

Main Results:

• Both gentamicin and tobramycin exhibited minimal and variable non-specific binding to human serum.
• Gentamicin displayed less than 15% non-specific binding.
• Tobramycin showed less than 30% non-specific binding.
• Scatchard analysis did not reveal evidence of specific binding proteins for either drug within the tested concentration range.

Conclusions:

• Gentamicin and tobramycin demonstrate predominantly non-specific binding to human serum.
• The absence of identified specific binding proteins suggests that protein binding does not significantly influence the pharmacokinetics of these drugs.
• Further research may explore other factors affecting aminoglycoside distribution and elimination.